SB 525334

Known as: SB-525334, SB525334 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
0246820052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Although invasive and metastatic progression via the epithelial-mesenchymal transition (EMT) and acquisition of resistance to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
We investigated activated microglia in ischemic brain lesions from rats that had been subjected to transient middle cerebral… (More)
Is this relevant?
2014
2014
Scleroderma (systemic sclerosis) is a connective tissue disease that affects various organ systems; the treatment of scleroderma… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to idiopathic pulmonary fibrosis… (More)
Is this relevant?
2013
2013
Periostin (POSTN) is an extracellular matrix protein expressed predominantly in periodontal ligament (PDL) cells. The aim of this… (More)
Is this relevant?
2011
2011
Microvascular mural or perivascular cells are required for the stabilization and maturation of the remodeling vasculature… (More)
Is this relevant?
2009
2009
Mutations in the gene for the transforming growth factor (TGF)-beta superfamily receptor, bone morphogenetic protein receptor II… (More)
Is this relevant?
2007
2007
PURPOSE Transforming growth factor beta (TGF-beta), which generally stimulates the growth of mesenchymally derived cells but… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2007
2007
Activin receptor-like kinase 5 (ALK5) is a type I receptor of transforming growth factor (TGF)-beta. ALK5 inhibition has been… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
SB-525334 (6-[2-tert-butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline) has been characterized as a potent and… (More)
Is this relevant?